Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
5.32
+0.22 (4.31%)
At close: Apr 28, 2026, 4:00 PM EDT
5.36
+0.04 (0.75%)
Pre-market: Apr 29, 2026, 5:32 AM EDT

Enveric Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Net Income
-8.77-9.57-17.29-18.47-48.98
Upgrade
Depreciation & Amortization
0.20.340.410.440.68
Upgrade
Loss (Gain) From Sale of Assets
---0--
Upgrade
Asset Writedown & Restructuring Costs
---7.4538.68
Upgrade
Stock-Based Compensation
0.831.562.152.6212.63
Upgrade
Other Operating Activities
-0.10.370.82-8.97-15.66
Upgrade
Change in Accounts Payable
-0.41-0.83-0.10.260.38
Upgrade
Change in Other Net Operating Assets
0.120.41-0.07-0.480.8
Upgrade
Operating Cash Flow
-8.14-7.73-14.09-17.15-11.46
Upgrade
Capital Expenditures
---0.01-0.58-0.19
Upgrade
Sale of Property, Plant & Equipment
--0.02--
Upgrade
Cash Acquisitions
----3.06
Upgrade
Sale (Purchase) of Intangibles
-----0.68
Upgrade
Investing Cash Flow
--0.01-0.582.19
Upgrade
Issuance of Common Stock
10.586.05-17.2224.9
Upgrade
Other Financing Activities
-1.62-1.340.96-
Upgrade
Financing Cash Flow
10.587.67-1.3418.1824.9
Upgrade
Foreign Exchange Rate Adjustments
-00.01-0.01-0.080.14
Upgrade
Net Cash Flow
2.44-0.05-15.440.3715.78
Upgrade
Free Cash Flow
-8.14-7.73-14.1-17.73-11.65
Upgrade
Free Cash Flow Per Share
-24.32-184.36-1175.46--
Upgrade
Cash Interest Paid
---0.010.01
Upgrade
Cash Income Tax Paid
-0.010.01--
Upgrade
Levered Free Cash Flow
-4.79-4.16-9.9-8.38-1.75
Upgrade
Unlevered Free Cash Flow
-4.79-4.16-9.9-8.38-1.75
Upgrade
Change in Working Capital
-0.3-0.42-0.17-0.221.19
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.